Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Heparinoid ointment for infantile facial eczema: prospective split-face study
jRCT1041190003Recruiting
- Start
- Dec 2020
- Countries
- 1
01
Overview
Single-blind trial of mucopolysaccharide polysulphate in atopic dermatitis (AD) (2 arms). Primary endpoint: Change in severity score of eczema. Started Dec 2020; status: recruiting.
02
Drugs
mucopolysaccharide polysulphate
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on jRCT1041190003.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1041190003.